Characterization of Hepatitis B Surface Proteins in HBeAg-positive Patients with Chronic Hepatitis B (CHB) Treated With PegInterferon Alfa-2a (40KD)

被引：0
|
作者：
Rinker, Franziska [1 ,2 ]
Bremer, Corinna M. [3 ,4 ]
Wiegand, Steffen B. [1 ]
Bremer, Birgit [1 ]
Manns, Michael P. [1 ,2 ]
Wedemeyer, Heiner [1 ,2 ]
Yang, Lei [5 ]
Pavlovic, Vedran [6 ]
Wat, Cynthia [6 ]
Glebe, Dieter [3 ,4 ]
Kraft, Anke R. [1 ]
Cornberg, Markus [1 ,2 ]
机构：
[1] Hannover Med Sch, Gastroenterol Hepatol & Endocrinol, Hannover, Germany
[2] German Ctr Infect Res DZIF, Hannover, Germany
[3] Univ Giessen, Natl Reference Ctr Hepatitis B&D Viruses, Inst Med Virol, D-35390 Giessen, Germany
[4] German Ctr Infect Res DZIF, Giessen, Germany
[5] Roche Prod Ltd, Shanghai, Peoples R China
[6] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2026
引用
收藏
页码：1196A / 1197A
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Peginterferon alfa-2a (40KD) in HBeAg-positive Chronic Hepatitis B Patients
    Caruntu, Florin Alexandru
    Streinu-Cercel, Adrian
    Gheorghe, Liliana Simona
    Grigorescu, Mircea
    Sporea, Ioan
    Stanciu, Carol
    Andronescu, Dan
    Voinea, Florea
    Diculescu, Mircea
    Oproiu, Alexandru
    Voiosu, Rodu
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2009, 18 (04) : 425 - 431
  • [2] COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON ALFA-2A (40KD) IN HBEAG-POSITIVE CHRONIC HEPATITIS B IN POLAND
    Jakubczyk, M.
    Paweska, J.
    Niewada, M.
    Berak, H.
    Szkultecka-Debek, M.
    Russel-Szymczyk, M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A275 - A275
  • [3] Enhanced pharmacokinetics (PK) and pharmacodynamics (PD) of peginterferon alfa-2a (40KD) (PEGASYS®) vs conventional interferon alfa-2a in HBeAg-positive chronic hepatitis B (CHB)
    Choudhury, S
    Wang, YJ
    Thongasawat, S
    Minde, Z
    Chan, WY
    Piratvisuth, T
    Yuan, R
    [J]. ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER MEETING 2002, 2002, : 95 - 100
  • [4] Response to peginterferon alfa-2a (40KD) (PEGASYS) treatment in patients with bridging fibrosis in HBeAg-positive and HBeAg-negative chronic hepatitis B
    Cooksley, Graham
    Lau, George
    Marcellin, Patrick
    Piratvisuth, Teerha
    Lai, Ming-Yang
    Bonino, Ferruccio
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A32 - A32
  • [5] Predicting response to peginterferon alfa-2a (40 KD) (PEGASYS®) in Asian patients with HBeAg-positive chronic hepatitis B
    Cooksley, Graham
    Chow, Wan Cheng
    Piratvisuth, Teerha
    Lau, George K. K.
    Mccloud, Philip
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A108 - A108
  • [6] CHANGES IN HBEAG LEVELS AMONG PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B TREATED WITH PEGINTERFERON ALFA-2A [40KD] ENROLLED IN THE S-COLLATE COHORT STUDY
    Lou, GuoQiang
    Marcellin, Patrick
    Xie, Yao
    Chen, Xiao P.
    Chen, Yong-Ping
    Rothe, Vivien
    Regep, Loredana
    Martins, Eduardo B.
    Jia, Jidong
    Wei, Lai
    [J]. HEPATOLOGY, 2010, 52 (04) : 537A - 537A
  • [7] Evidence for the efficacy of peginterferon alfa-2a (40 KD) (pegasys) in the treatment of HBeAg-positive chronic hepatitis B (CHB) and impact of baseline factors
    Cooksley, WGE
    Piratvisuth, T
    Wang, YJ
    Mahachai, V
    Chao, YC
    Tanwandee, T
    Chutaputti, A
    Chang, WY
    Zahm, FE
    Pluck, N
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 8 - 8
  • [8] RESPONSE-GUIDED PEGINTERFERON ALFA-2a (PegIFN alfa-2a) THERAPY IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B (CHB)
    Hou, J.
    Ma, H.
    Sun, J.
    Xie, Q.
    Xie, Y.
    Sun, Y.
    Wang, H.
    Shi, G.
    Wan, M.
    Niu, J.
    Ning, Q.
    Yu, Y.
    Xie, Y.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S432 - S433
  • [9] Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
    Lau, GKK
    Piratvisuth, T
    Luo, KX
    Marcellin, P
    Thongsawat, S
    Cooksley, G
    Gane, E
    Fried, MW
    Chow, WC
    Paik, SW
    Chang, WY
    Berg, T
    Flisiak, R
    McCloud, P
    Pluck, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2682 - 2695
  • [10] Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a
    Rinker, Franziska
    Bremer, Corinna M.
    Schroeder, Kathrin
    Wiegand, Steffen B.
    Bremer, Birgit
    Manns, Michael P.
    Kraft, Anke R.
    Wedemeyer, Heiner
    Yang, Lei
    Pavlovic, Vedran
    Wat, Cynthia
    Gerlich, Wolfram H.
    Glebe, Dieter
    Cornberg, Markus
    [J]. LIVER INTERNATIONAL, 2020, 40 (02) : 324 - 332
12345